In the last 12 months, insiders at HOOKIPA Pharma Inc. ($HOOK) filed 18 transactions with the SEC: 0 open-market purchases totaling $0 and 3 sales totaling $60,046. Net insider sentiment: net selling.
HOOKIPA Pharma Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Peters Malte (Chief Executive Officer) — 3 transactions totaling $47,526
- Coelho Mary Theresa (EVP and CFO) — 2 transactions totaling $12,520
- Winderlich Mark (Chief Development Officer) — 2 transactions totaling $0
- Kaufman David Ross (Not found) — 1 transaction totaling $0
- Cassidy Sean A (Not found) — 1 transaction totaling $0
View all SEC Filings for HOOKIPA Pharma Inc. (HOOK).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 19, 2025 | Peters Malte | Chief Executive Officer | S | Common Stock | 25172 | $0.82 | 54,347.0000 | 12,544,777 | 31.66% | 0.20% |
| July 22, 2025 | Coelho Mary Theresa | EVP and CFO | S | Common Stock | 13609 | $0.92 | 56,266.0000 | 12,544,777 | 19.48% | 0.11% |
| July 22, 2025 | Peters Malte | Chief Executive Officer | S | Common Stock | 29176 | $0.92 | 79,519.0000 | 12,544,777 | 26.84% | 0.23% |
| July 22, 2024 | Peters Malte | Chief Executive Officer | A | Common Stock | 108695 | $0.00 | 108,695.0000 | 12,538,774 | 9999.99% | 0.87% |
| July 22, 2024 | Cassidy Sean A | Not found | A | Stock Option (Right to Buy) | 9800 | $0.00 | 9,800.0000 | 12,538,774 | 9999.99% | 0.08% |
| July 22, 2024 | Coelho Mary Theresa | EVP and CFO | A | Common Stock | 69875 | $0.00 | 69,875.0000 | 12,538,774 | 9999.99% | 0.56% |
| June 17, 2024 | van de Winkel Jan | Not found | A | Stock Option (Right to Buy) | 98000 | $0.00 | 98,000.0000 | 12,597,559 | 9999.99% | 0.78% |
| June 17, 2024 | Kaufman David Ross | Not found | A | Stock Option (Right to Buy) | 49000 | $0.00 | 49,000.0000 | 12,597,559 | 9999.99% | 0.39% |
| June 17, 2024 | O'Neill Julie | Not found | A | Stock Option (Right to Buy) | 49000 | $0.00 | 49,000.0000 | 12,597,559 | 9999.99% | 0.39% |
| June 17, 2024 | Coelho Mary Theresa | Not found | A | Stock Option (Right to Buy) | 49000 | $0.00 | 49,000.0000 | 12,597,559 | 9999.99% | 0.39% |
| June 17, 2024 | Reilly Timothy P. | Not found | A | Stock Option (Right to Buy) | 49000 | $0.00 | 49,000.0000 | 12,597,559 | 9999.99% | 0.39% |
| June 17, 2024 | Peters Malte | Not found | A | Stock Option (Right to Buy) | 49000 | $0.00 | 49,000.0000 | 12,597,559 | 9999.99% | 0.39% |
| April 15, 2024 | Aldag Jorn | Chief Executive Officer | A | Stock Option (Right to Buy) | 971400 | $0.00 | 971,400.0000 | 12,597,559 | 9999.99% | 7.71% |
| April 15, 2024 | Winderlich Mark | Chief Development Officer | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 12,597,559 | 9999.99% | 1.98% |
| April 15, 2024 | Winderlich Mark | Chief Development Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 12,597,559 | 9999.99% | 0.40% |
| April 15, 2024 | Kandera Reinhard | Chief Financial Officer | A | Stock Option (Right to Buy) | 406200 | $0.00 | 406,200.0000 | 12,597,559 | 9999.99% | 3.22% |
| April 15, 2024 | Necina Roman | Chief Operations Officer | A | Stock Option (Right to Buy) | 367300 | $0.00 | 367,300.0000 | 12,597,559 | 9999.99% | 2.92% |
| April 15, 2024 | Orlinger Klaus | Chief Scientific Officer | A | Stock Option (Right to Buy) | 367300 | $0.00 | 367,300.0000 | 12,597,559 | 9999.99% | 2.92% |